897043-47-9

Usage

Uses

Used in Pharmaceutical Industry:
Tert-Butyl 3-allyl-4-hydroxypyrrolidine-1-carboxylate is used as a key intermediate in the synthesis of various pharmaceuticals and fine chemicals. Its unique structure and the ability to modify its chemical properties make it a valuable component in medicinal chemistry.
Used in Research and Development:
Tert-Butyl 3-allyl-4-hydroxypyrrolidine-1-carboxylate is utilized in research and development for the creation of new drugs and therapeutic agents, thanks to its potential applications in medicinal chemistry and its role as a building block in organic synthesis.

Upstream product

• 114214-49-2 1-tert-butoxycarbonyl-3,4-epoxypyrrolidine 
• 1730-25-2 allylmagnesium bromide 
• 73286-70-1 N-(tert-butoxycarbonyl)-3-pyrroline 

Downstream Products

• 120871-73-0 3-allyl-4-oxopyrrolidine-1-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

Compound as well as preparation method and medical application thereof

The invention provides a compound as well as a preparation method and medical application thereof, the compound has a structure as shown in a general formula (I), and can also be a tautomer, a mesomer, a raceme, an enantiomer, a diastereoisomer, or a mixture form thereof, or a pharmaceutically acceptable salt thereof. According to the compound with the structure as shown in the general formula (I)provided by the invention, a specific main chain structure and a corresponding substituent group are selected, so that the obtained compound can be used as an arginase inhibitor, is relatively high in activity, and has a potential treatment prospect in various diseases.

PYRROLIDYL DERIVATIVES OF HETEROAROMATIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS

The invention pertains to new pyrrolidyl derivatives of benzo-fused aza heteroaromatic compounds that serve as effective phosphodiesterase (PDE) inhibitors. The invention also relates to compounds that are selective inhibitors of PDE-IO. The invention fur